GASTROINTESTINAL
INFECTIONS (GI)
Augustus Laboratories offers advanced multiplex molecular diagnostic testing for gastrointestinal infections, capable of detecting and identifying numerous pathogens in a single comprehensive test. Utilizing state-of-the-art PCR-based technologies, we provide rapid same-day delivery of patient results upon receipt at our laboratories, ensuring high sensitivity, specificity, and accuracy in molecular detection. The Augustus Gastrointestinal Pathogen Test identifies:
BACTERIAL
- Campylobacter jejuni, Campylobacter coli, Campylobacter upsaliensis
- Clostridioides (Clostridium) difficile, toxin A/B
- E. coli O157
- Plesiomonas shigelloides
- Salmonella enterica
- Shiga Toxin-Producing E. coli
- Shigella sonnei, Enteroinvasive E. coli (EIEC)
- Vibrio cholerae
- Vibrio vulnificus, Vibrio parahaemolyticus
VIRAL
- Hepatitis A
- 1 WHO
- Norovirus GI/GII
- Rotavirus
- Sapovirus, Astrovirus
PARASITIC
- Cryptosporidium parvum
- Cyclospora cayetanensis
- Cystosiospora belli
- Entamoeba histolytica
- Giardia lamblia
ANTIBIOTIC RESISTANCE
- Carbapenemase and Metallo-Betalactamase Resistance Class A and C Beta-lactams resistance
- Class A and Plasmid ESBL Resistance
- Class C Beta-lactams resistance
- Class D Betalactamase Resistance
- Dihydrofolate and Sulfonamide Resistance
- Quinolone Resistance
Clinical Solution
Augustus Laboratories provides clinicians with state-of-the-art molecular methodologies for detecting, quantifying, and identifying resistance genes in pathogens. Our technology platform delivers rapid and precise results, integrating antibiotic resistance data alongside regional sensitivity profiles, medication costs, antibiotic efficacy, FDA guidelines, and personalized pharmacy recommendations.
This patient-centered approach empowers providers to make informed treatment decisions, mitigating risks such as inappropriate therapy, excessive costs, adverse drug events, and disease progression.
